Recent Progress in Ferroptosis Inducers for Cancer Therapy

Chen Liang1, Xinglin Zhang2, Mengsu Yang1,3

  • 1Department of Biomedical Sciences, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong, 999077, China.

Insights

Ferroptosis, a form of cell death linked to metabolism, shows promise for cancer therapy. Researchers are developing ferroptosis-inducing agents, including small molecules and nanomaterials, to combat resistant cancers.

Area of Science:

  • Biochemistry
  • Oncology
  • Materials Science

Background:

  • Ferroptosis is a regulated cell death pathway connecting metabolism, redox biology, and health.
  • Emerging evidence highlights its potential in cancer therapy, especially for drug-resistant malignancies.

Purpose of the Study:

  • To review recent advances in ferroptosis-inducing agents for cancer therapy.
  • To summarize the basis of ferroptosis and its therapeutic feasibility.
  • To delineate the design, mechanisms, and applications of ferroptosis inducers.

Main Methods:

  • Literature review of ferroptosis inducers.
  • Analysis of small molecules and nanomaterials as ferroptosis agents.
  • Discussion of chemical, materials science, and cancer biology intersections.

Main Results:

  • Ferroptosis induction is a feasible strategy for cancer treatment.
  • Various ferroptosis inducers, including novel nanomaterials, have been developed.
  • These agents show potential in eradicating aggressive and resistant cancers.

Conclusions:

  • Ferroptosis-inducing agents represent a promising new avenue for cancer therapy.
  • Further research is needed to address challenges and explore future directions in this field.
  • The interdisciplinary development of ferroptosis inducers holds significant therapeutic potential.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K